However, inhibition of tumour lymphangiogenesis using a soluble VEGFR-3 was not sufficient to block lymph node metastasis in a mouse model of prostate cancer suggesting that lymphangiogenesis is not an essential requirement for lymphatic spread in all tumours (Wong et al, 2005). The gene discussed is FLT4; the disease is neoplasm.